How should ventricular tachycardia be managed in stable versus unstable patients?

Management of Ventricular Tachycardia: Stable vs Unstable Patients

For unstable ventricular tachycardia (systolic BP <80 mmHg or altered mentation), perform immediate synchronized cardioversion without delay; for stable monomorphic VT, procainamide or synchronized cardioversion are first-line options, with electrical cardioversion being most efficacious overall. 1

Immediate Assessment: Stable vs Unstable

The critical first decision point is hemodynamic stability. Unstable VT is defined by:

• Systolic blood pressure <80 mmHg
• Altered mental status
• Signs of shock
• Acute heart failure
• Ischemic chest discomfort directly attributable to the tachycardia 1

Important caveat: With ventricular rates <150 bpm in the absence of ventricular dysfunction, the tachycardia is more likely secondary to an underlying condition rather than the primary cause of instability 2.

Management Algorithm for Unstable VT

Immediate synchronized cardioversion is the only appropriate intervention 1, 3:

• Use maximum energy setting if device-specific recommendations unknown
• Do not delay for IV access or medications
• If cardioversion fails after 1-2 attempts, administer IV amiodarone (300 mg IV push, or 150 mg if <45 kg) or lidocaine (100 mg IV push, or 50 mg if <45 kg) 3

Critical pitfall: Never administer verapamil or diltiazem for wide-complex tachycardia—these can cause profound hypotension, shock, and cardiac arrest 1. This is a Class III (Harm) recommendation.

Management Algorithm for Stable Monomorphic VT

For hemodynamically stable patients, you have time for diagnostic workup and pharmacologic intervention:

Step 1: Initial Assessment

• Obtain 12-lead ECG
• Establish IV access
• Continuous cardiac monitoring
• Assess for acute ischemia/MI

Step 2: Consider Diagnostic Maneuvers (Optional)

For stable, regular, monomorphic wide-complex tachycardia where the diagnosis is uncertain:

• Adenosine may be attempted (6 mg rapid IV push, then 12 mg if needed) for diagnostic purposes 1
• This can help differentiate SVT with aberrancy from VT
• Critical warning: Adenosine will not terminate true VT and may cause profound hypotension or precipitate VF 1. Have defibrillator immediately available.
• Never use adenosine for unstable, irregular, or polymorphic wide-complex tachycardia 1

Step 3: Definitive Treatment Options

First-line pharmacologic therapy (in order of preference based on 2025 AHA guidelines):

1. Procainamide (preferred antiarrhythmic) 1:

   • Dose: 20-50 mg/min IV until arrhythmia suppressed, hypotension develops, QRS widens >50%, or maximum 17 mg/kg given
   • Maintenance: 1-4 mg/min
   • Avoid if: Prolonged QT interval or CHF present
   • Evidence shows similar efficacy to sotalol and superior to amiodarone for stable monomorphic VT 1

2. Sotalol 1:

   • Similar efficacy to procainamide
   • Avoid if: Prolonged QT interval

3. Amiodarone 1:

   • 150 mg IV over 10 minutes
   • Can repeat if VT recurs
   • Maintenance: 1 mg/min for first 6 hours
   • Note: Not more effective than procainamide for stable VT, but commonly used 1

4. Lidocaine (second-line) 1, 2:

   • Less effective than procainamide, sotalol, and amiodarone
   • Unclear if more efficacious than placebo 1
   • Consider only if other agents unavailable

First-line electrical therapy:

• Synchronized cardioversion is the most efficacious treatment overall and should be used if pharmacologic therapy fails or is contraindicated 1, 3, 4

Special Considerations for Stable VT

If acute myocardial ischemia/infarction present:

• Prioritize ACS therapy
• IV amiodarone or lidocaine preferred 3
• Consider urgent cardiac catheterization

If polymorphic VT with prolonged QT (Torsades de Pointes):

• Remove/correct precipitant (medications, electrolytes)
• IV magnesium sulfate
• Overdrive pacing (atrial preferred)
• Non-selective beta-blocker (propranolol preferred)
• IV lidocaine if refractory 3

Critical Safety Points

Never co-administer multiple antiarrhythmic drugs—their combined effects are arrhythmogenic 1. If one drug fails, proceed to electrical cardioversion rather than adding another medication.

Always have defibrillator immediately available when administering any antiarrhythmic drug, as these medications may paradoxically convert stable VT to unstable VT, VF, or more rapid malignant rhythms 1.

Electrical Storm (≥3 episodes in 24 hours)

If VT recurs despite initial treatment:

• Non-selective beta-blocker (propranolol preferred over metoprolol) 3
• IV amiodarone infusion
• Consider sedation/general anesthesia
• Involve cardiac electrophysiology specialist immediately
• Treat acute heart failure if present 3

Post-Conversion Management

After successful rhythm conversion, maintain antiarrhythmic infusion to prevent recurrence and arrange urgent cardiology consultation for risk stratification and consideration of implantable cardioverter-defibrillator (ICD) evaluation 3, 5.